Receptor activator of nuclear factor κB ligand and osteoprotegerin regulation of bone remodeling in health and disease

AE Kearns, S Khosla, PJ Kostenuik - Endocrine reviews, 2008 - academic.oup.com
Osteoclasts and osteoblasts dictate skeletal mass, structure, and strength via their respective
roles in resorbing and forming bone. Bone remodeling is a spatially coordinated lifelong …

Clinical impact and cellular mechanisms of iron overload-associated bone loss

V Jeney - Frontiers in pharmacology, 2017 - frontiersin.org
Diseases/conditions with diverse etiology, such as hemoglobinopathies, hereditary
hemochromatosis and menopause, could lead to chronic iron accumulation. This condition …

Coordination of PGC-1β and iron uptake in mitochondrial biogenesis and osteoclast activation

K Ishii, T Fumoto, K Iwai, S Takeshita, M Ito… - Nature medicine, 2009 - nature.com
Osteoclasts are acid-secreting polykaryons that have high energy demands and contain
abundant mitochondria. How mitochondrial biogenesis is integrated with osteoclast …

Effects of extracellular magnesium extract on the proliferation and differentiation of human osteoblasts and osteoclasts in coculture

L Wu, F Feyerabend, AF Schilling, R Willumeit-Römer… - Acta biomaterialia, 2015 - Elsevier
Coculture of osteoblasts and osteoclasts is a subject of interest in the understanding of how
magnesium (Mg)-based implants influence the bone metabolism and remodeling upon …

[HTML][HTML] Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin

E Balogh, E Tolnai, B Nagy Jr, B Nagy, G Balla… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Osteogenic differentiation of multipotent mesenchymal stem cells (MSCs) plays a crucial role
in bone remodeling. Numerous studies have described the deleterious effect of iron …

New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia

E Voskaridou, E Terpos - British Journal of Haematology, 2004 - Wiley Online Library
Osteoporosis represents an important cause of morbidity in adult patients with thalassaemia
major (TM). The pathogenesis of osteoporosis in TM is multifactorial, and includes bone …

Complications of thalassemia major and their treatment

C Borgna-Pignatti, MR Gamberini - Expert review of hematology, 2011 - Taylor & Francis
The life of patients with thalassemia has improved both in duration and in quality in
industrialized countries. Complications are still common and include heart disease (heart …

Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis

S Jabbar, J Drury, JN Fordham, HK Datta… - Journal of clinical …, 2011 - jcp.bmj.com
Background Osteoprotegerin (OPG) and receptor activator of nuclear factor κ B ligand
(RANKL) play a critical role in the regulation of bone turnover, but the relative importance of …

Bone disease and skeletal complications in patients with β thalassemia major

R Haidar, KM Musallam, AT Taher - Bone, 2011 - Elsevier
Increased survival in patients with β thalassemia major (TM) allowed for several
complications of the disease and its treatment to manifest, one of which is bone disease …

Bone disease in thalassemia: a molecular and clinical overview

P Wong, PJ Fuller, MT Gillespie, F Milat - Endocrine reviews, 2016 - academic.oup.com
Thalassemia bone disease is a common and severe complication of thalassemia—an
inherited blood disorder due to mutations in the α or β hemoglobin gene. In its more severe …